Galapagos Stock

Galapagos FCF Margin

The Free Cash Flow Margin of Galapagos (GLPG.AS) as of Aug 7, 2026 is -18.20 %. In the previous year, Free Cash Flow Margin was -145.89 % — a change of -87.53% (higher).

FCF Margin

-18.20 %

YoY

-87.53%

Last updated:

Free Cash Flow Margin of Galapagos is 2026 -18.20 % . Free Cash Flow Margin of Galapagos was 2025 -145.89 % . It decreases by -87.53% higher compared to the previous year.
Access this data via the Eulerpool API

Galapagos Stock analysis

What does Galapagos do? Galapagos NV is a Belgian biopharmaceutical company focused on the development of novel drugs, particularly for autoimmune diseases and fibrosis. The company was founded in 1999 by Onno van de Stolpe and is headquartered in Mechelen, Belgium. Galapagos is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Galapagos stock

Free Cash Flow Margin of Galapagos is -18.20 % in 2026.

Free Cash Flow Margin of Galapagos changed from -145.89 % to -18.20 %, representing a -87.53% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow Margin Galapagos since 2006 – with annual values, charts, and detailed analysis.

FCF Margin measures the percentage of revenue converted to free cash flow. It indicates how efficiently a company generates cash from its operations.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Free Cash Flow Margin's Galapagos with sector peers and the industry average to assess whether it is attractive.

To evaluate Free Cash Flow Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Free Cash Flow Margin.

Access this data via the Eulerpool API

Margins — Galapagos

All Key Metrics — Galapagos